(S)-4-Isopropyl-3-propionyloxazolidin-2-one

Catalog No. :
ACITFG916
CAS No. :
77877-19-1
Molecular Formula :
C9H15NO3
Molecular Weight :
185.22

IUPAC Name:(S)-4-isopropyl-3-propionyloxazolidin-2-one

(S)-4-Isopropyl-3-propionyloxazolidin-2-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$116.00Login to see priceIn stockIn stock
25g98%$458.00Login to see priceIn stockIn stock
100g98%$1649.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-4-Isopropyl-3-propionyloxazolidin-2-one
IUPAC Name(S)-4-isopropyl-3-propionyloxazolidin-2-one
MDL No.MFCD00043401
Molecular FormulaC9H15NO3
Molecular Weight185.22
SMILESO=C1OC[C@H](C(C)C)N1C(CC)=O
InChI KeyHOWPHXVPNNPSAZ-SSDOTTSWSA-N
Synonym(S)-(+)-4-Isopropyl-3-propionyl-2-oxazolidinone, 98% | HOWPHXVPNNPSAZ-SSDOTTSWSA-N | TD8073 | AKOS015838433 | AS-54710 | (S)-4-Isopropyl-3-propionyl-2-oxazolidinone | (S)-(+)-4-Isopropyl-3-propionyl-2-oxazolidinone | 2-Oxazolidinone, 4-(1-methylethyl)-3-(
CAS No.77877-19-1
PubChem CID853160

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACITFG916 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIXBD817 route compound structure diagram
    ACIXBD81717016-83-0 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACITFG916 route product structure diagram
    ACITFG91677877-19-1 In Stock
Inquiry

2. ACITFG916 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIXBD817 route compound structure diagram
    ACIXBD81717016-83-0 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACITFG916 route product structure diagram
    ACITFG91677877-19-1 In Stock
Inquiry

Comments (0)